GENE ONLINE|News &
Opinion
Blog

IL-17A
Novartis’ IL-17 Inhibitor Shines in Late-Stage Psoriatic Arthritis Trial
2020-11-06
Cosentyx Bags EU Approval for First-Line Treatment of Pediatric Psoriasis
2020-08-05
Novartis’ Axial Spondyloarthritis Drug, Cosentyx Shines in Phase 3 Study
2020-06-08
LATEST
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
Gilead Strikes Again: $415M Bet on ADCs with Tubulis Deal
2024-12-03
FDA Investigates Reports of Blood Cancer Cases Linked to Gene Therapy
2024-12-02
EVENT
Scroll to Top